I am seeking all information about the CO-200-201 trial that is supposed to start in Europe this year (PI-2301 copolymer, Peptimmune Incl. USA). There is no information on clinicaltrials.com.
Does anybody have details about the trial? (how is it designed, what phase, the main goal, age of participants, type of MS, inclusion and exclusion criteria, primary and secondary outcomes, etc...)
Thanks in advance!